Clinical Trials Logo

Clinical Trial Summary

Chronic Obstructive Pulmonary Patients is a defined by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. It is associated with an atrophy of the skeletal muscle that impairs the patient's prognosis. The biological mechanisms of this muscle atrophy have not been elucidated, and the "spill-over theory" has recently emerged. Indeed, in COPD patients, the pulmonary inflammation is associated with a systemic low-grade inflammation, and the increased pro-inflamatory molelcules in the blood - which constitute the cellular micro-environement of the muscle fibre - could activate the mechanisms of the cell atrophy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03197909
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date July 6, 2017
Completion date January 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT00105183 - EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection Phase 3